(Q38190360)

30 August 2017

1 reference

title

RET revisited: expanding the oncogenic portfolio (English)

1 reference

30 August 2017

Lois M Mulligan

1

1 reference

30 August 2017

language of work or name

English

0 references

publication date

1 March 2014

1 reference

30 August 2017

published in

Nature Reviews Cancer

1 reference

30 August 2017

volume

14

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

173-186

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc3680

30 August 2017

exact match

0 references

cites work

Transcriptional repression of the RET proto-oncogene by a mitogen activated protein kinase-dependent signalling pathway

1 reference

Transcriptional regulation of RET by Nkx2-1, Phox2b, Sox10, and Pax3.

31 March 2020

1 reference

Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer

31 March 2020

1 reference

HOXB5 cooperates with NKX2-1 in the transcription of human RET.

31 March 2020

1 reference

RET and GDNF mutations are rare in fetuses with renal agenesis or other severe kidney development defects

31 March 2020

1 reference

Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene.

31 March 2020

1 reference

A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk.

31 March 2020

1 reference

RNA sequencing of MCF-7 breast cancer cells identifies novel estrogen-responsive genes with functional estrogen receptor-binding sites in the vicinity of their transcription start sites

31 March 2020

1 reference

The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells

31 March 2020

1 reference

Conservation of RET proto-oncogene splicing variants and implications for RET isoform function

31 March 2020

1 reference

Molecular modeling of the extracellular domain of the RET receptor tyrosine kinase reveals multiple cadherin-like domains and a calcium-binding site

31 March 2020

1 reference

Mammal-restricted elements predispose human RET to folding impairment by HSCR mutations

31 March 2020

1 reference

Direct interactions among Ret, GDNF and GFRalpha1 molecules reveal new insights into the assembly of a functional three-protein complex

31 March 2020

1 reference

Structural studies of GDNF family ligands with their receptors-Insights into ligand recognition and activation of receptor tyrosine kinase RET.

31 March 2020

1 reference

Alternative splicing results in RET isoforms with distinct trafficking properties.

31 March 2020

1 reference

RET(MEN 2B) is active in the endoplasmic reticulum before reaching the cell surface

31 March 2020

1 reference

Expression of the receptor tyrosine kinase Ret on the plasma membrane is dependent on calcium

31 March 2020

1 reference

Acidification of the Golgi apparatus is indispensable for maturation but not for cell surface delivery of Ret.

31 March 2020

1 reference

RET tyrosine kinase signaling in development and cancer

31 March 2020

1 reference

GFRalpha-mediated localization of RET to lipid rafts is required for effective downstream signaling, differentiation, and neuronal survival

31 March 2020

1 reference

The GDNF family: signalling, biological functions and therapeutic value

31 March 2020

1 reference

Evolution of the GDNF family ligands and receptors.

31 March 2020

1 reference

Phosphorylation of protocadherin proteins by the receptor tyrosine kinase Ret

31 March 2020

1 reference

RET-mediated cell adhesion and migration require multiple integrin subunits

31 March 2020

1 reference

Ret is a multifunctional coreceptor that integrates diffusible- and contact-axon guidance signals

31 March 2020

1 reference

Crosstalk between VEGF-A/VEGFR2 and GDNF/RET signaling pathways

31 March 2020

1 reference

Retracted: A Cross-Talk between TrkB and Ret Tyrosine Kinases Receptors Mediates Neuroblastoma Cells Differentiation

31 March 2020

1 reference

GDNF promotes tubulogenesis of GFRalpha1-expressing MDCK cells by Src-mediated phosphorylation of Met receptor tyrosine kinase

31 March 2020

1 reference

Structure and physiology of the RET receptor tyrosine kinase

31 March 2020

1 reference

Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor

31 March 2020

1 reference

Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.

31 March 2020

1 reference

Coordinated activation of autophosphorylation sites in the RET receptor tyrosine kinase: importance of tyrosine 1062 for GDNF mediated neuronal differentiation and survival

31 March 2020

1 reference

Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway.

31 March 2020

1 reference

Critical and distinct roles for key RET tyrosine docking sites in renal development

31 March 2020

1 reference

Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene

31 March 2020

1 reference

GDNF-mediated signaling via RET tyrosine 1062 is essential for maintenance of spermatogonial stem cells.

31 March 2020

1 reference

The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma

31 March 2020

1 reference

RET PLCγ phosphotyrosine binding domain regulates Ca2+ signaling and neocortical neuronal migration.

31 March 2020

1 reference

Tyrosine 981, a novel ret autophosphorylation site, binds c-Src to mediate neuronal survival

31 March 2020

1 reference

MEN2A-RET-induced cellular transformation by activation of STAT3

31 March 2020

1 reference

Ras/ERK1/2-mediated STAT3 Ser727 phosphorylation by familial medullary thyroid carcinoma-associated RET mutants induces full activation of STAT3 and is required for c-fos promoter activation, cell mitogenicity, and transformation.

31 March 2020

1 reference

Novel mechanism of regulation of Rac activity and lamellipodia formation by RET tyrosine kinase

31 March 2020

1 reference

Protein-tyrosine phosphatase SHP2 contributes to GDNF neurotrophic activity through direct binding to phospho-Tyr687 in the RET receptor tyrosine kinase.

31 March 2020

1 reference

Targeted mutation of serine 697 in the Ret tyrosine kinase causes migration defect of enteric neural crest cells.

31 March 2020

1 reference

Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism.

31 March 2020

1 reference

A novel RET kinase-beta-catenin signaling pathway contributes to tumorigenesis in thyroid carcinoma.

31 March 2020

1 reference

The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation.

31 March 2020

1 reference

Differential interaction of Enigma protein with the two RET isoforms.

31 March 2020

1 reference

The neuronal scaffold protein Shank3 mediates signaling and biological function of the receptor tyrosine kinase Ret in epithelial cells

31 March 2020

1 reference

Phosphotyrosine 1062 is critical for the in vivo activity of the Ret9 receptor tyrosine kinase isoform

31 March 2020

1 reference

Ret-dependent cell rearrangements in the Wolffian duct epithelium initiate ureteric bud morphogenesis.

31 March 2020

1 reference

To bud or not to bud: the RET perspective in CAKUT.

31 March 2020

1 reference

Regulation of cell fate decision of undifferentiated spermatogonia by GDNF.

31 March 2020

1 reference

Glial cell-line derived neurotrophic factor-mediated RET signaling regulates spermatogonial stem cell fate

31 March 2020

1 reference

Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret

31 March 2020

1 reference

Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesis

31 March 2020

1 reference

Glial cell line-derived neurotrophic factor-dependent recruitment of Ret into lipid rafts enhances signaling by partitioning Ret from proteasome-dependent degradation

31 March 2020

1 reference

GDNF and GFRalpha: a versatile molecular complex for developing neurons

31 March 2020

1 reference

Expression and function of glial cell line-derived neurotrophic factor family ligands and their receptors on human immune cells

31 March 2020

1 reference

Induction of RET dependent and independent pro-inflammatory programs in human peripheral blood mononuclear cells from Hirschsprung patients.

31 March 2020

1 reference

Differential RET signaling pathways drive development of the enteric lymphoid and nervous systems

31 March 2020

1 reference

Tyrosine kinase receptor RET is a key regulator of Peyer's patch organogenesis

31 March 2020

1 reference

Hirschsprung disease, associated syndromes and genetics: a review

31 March 2020

1 reference

Traditional and targeted exome sequencing reveals common, rare and novel functional deleterious variants in RET-signaling complex in a cohort of living US patients with urinary tract malformations

31 March 2020

1 reference

Hirschsprung disease and congenital anomalies of the kidney and urinary tract (CAKUT): a novel syndromic association.

31 March 2020

1 reference

The many faces of RET dysfunction in kidney

31 March 2020

1 reference

Mutations in 12 known dominant disease-causing genes clarify many congenital anomalies of the kidney and urinary tract

31 March 2020

1 reference

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

31 March 2020

1 reference

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

31 March 2020

1 reference

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

31 March 2020

1 reference

Frequent association between MEN 2A and cutaneous lichen amyloidosis

31 March 2020

1 reference

Medullary thyroid cancer: management guidelines of the American Thyroid Association

31 March 2020

1 reference

Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective

31 March 2020

1 reference

Positive selection for new disease mutations in the human germline: evidence from the heritable cancer syndrome multiple endocrine neoplasia type 2B

31 March 2020

1 reference

Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlations.

31 March 2020

1 reference

Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update

31 March 2020

1 reference

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC

31 March 2020

1 reference

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis

31 March 2020

1 reference

Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations

31 March 2020

1 reference

Pheochromocytoma penetrance varies by RET mutation in MEN 2A

31 March 2020

1 reference

Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung's disease

31 March 2020

1 reference

Enteric nervous system development: migration, differentiation, and disease

31 March 2020

1 reference

Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10.

31 March 2020

1 reference

Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene

31 March 2020

1 reference

Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2B.

31 March 2020

1 reference

Structure and chemical inhibition of the RET tyrosine kinase domain

31 March 2020

1 reference

Catalytic specificity of protein-tyrosine kinases is critical for selective signalling

31 March 2020

1 reference

Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation

31 March 2020

1 reference

Familial prevalence and age of RET germline mutations: implications for screening

31 March 2020

1 reference

The clinical spectrum of RET proto-oncogene mutations in codon 790.

31 March 2020

1 reference

The clinical spectrum of multiple endocrine neoplasia type 2a caused by the rare intracellular RET mutation S891A.

31 March 2020

1 reference

A ten-year clinical update of a large RET p.Gly533Cys kindred with medullary thyroid carcinoma emphasizes the need for an individualized assessment of affected relatives.

31 March 2020

1 reference

Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors

31 March 2020

1 reference

RET-familial medullary thyroid carcinoma mutants Y791F and S891A activate a Src/JAK/STAT3 pathway, independent of glial cell line-derived neurotrophic factor.

31 March 2020

1 reference

Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma

31 March 2020

1 reference

Novel tandem germline RET proto-oncogene mutations in a patient with multiple endocrine neoplasia type 2B: report of a case and a literature review of tandem RET mutations with in silico analysis

31 March 2020

1 reference

RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2B.

31 March 2020

1 reference

The involvement of the RET variant G691S in medullary thyroid carcinoma enlightened by a meta-analysis study.

31 March 2020

1 reference

The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling.

31 March 2020

1 reference

Functional RET G691S polymorphism in cutaneous malignant melanoma

31 March 2020

1 reference

The RET G691S polymorphism is a germline variant in desmoplastic malignant melanoma

31 March 2020

1 reference

Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism.

31 March 2020

1 reference

Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome

31 March 2020

1 reference

Frequency of RET mutations in long- and short-segment Hirschsprung disease

31 March 2020

2 references

31 March 2020

12 December 2020

In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer.

1 reference

Multiple functional effects of RET kinase domain sequence variants in Hirschsprung disease.

31 March 2020

1 reference

Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2.

31 March 2020

1 reference

High penetrance of pheochromocytoma associated with the novel C634Y/Y791F double germline mutation in the RET protooncogene

31 March 2020

1 reference

RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma.

31 March 2020

1 reference

Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years

31 March 2020

1 reference

RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics.

31 March 2020

1 reference

RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose

31 March 2020

1 reference

High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation

31 March 2020

1 reference

Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells

31 March 2020

1 reference

DNA topoisomerases participate in fragility of the oncogene RET.

31 March 2020

1 reference

Molecular pathogenesis and mechanisms of thyroid cancer

31 March 2020

1 reference

Transcript level modulates the inherent oncogenicity of RET/PTC oncoproteins.

31 March 2020

1 reference

KIF5B-RET fusions in lung adenocarcinoma.

31 March 2020

1 reference

Identification of RET gene fusion by exon array analyses in "pan-negative" lung cancer from never smokers

31 March 2020

1 reference

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

31 March 2020

1 reference

RET, ROS1 and ALK fusions in lung cancer

31 March 2020

1 reference

Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas

31 March 2020

1 reference

RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer.

31 March 2020

1 reference

Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1

31 March 2020

1 reference

RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation.

31 March 2020

1 reference

Expression of glial cell line-derived neurotrophic factor family members and their receptors in pancreatic cancers

31 March 2020

1 reference

The relationship between overexpression of glial cell-derived neurotrophic factor and its RET receptor with progression and prognosis of human pancreatic cancer

31 March 2020

1 reference

Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves.

31 March 2020

1 reference

Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells

31 March 2020

1 reference

Endoneurial macrophages induce perineural invasion of pancreatic cancer cells by secretion of GDNF and activation of RET tyrosine kinase receptor

31 March 2020

1 reference

Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance.

31 March 2020

1 reference

A role for glial cell derived neurotrophic factor induced expression by inflammatory cytokines and RET/GFR alpha 1 receptor up-regulation in breast cancer

31 March 2020

1 reference

GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors

31 March 2020

1 reference

Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells

31 March 2020

1 reference

Artemin is oncogenic for human mammary carcinoma cells

31 March 2020

1 reference

The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancer

31 March 2020

1 reference

Differential expression of the RET gene in human acute myeloid leukemia.

31 March 2020

1 reference

Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression.

31 March 2020

1 reference

Investigation of the genes for RET and its ligand complex, GDNF/GFR alpha-I, in small cell lung carcinoma

31 March 2020

1 reference

RET protein expression in papillary renal cell carcinoma

31 March 2020

1 reference

Altered expression of RET proto-oncogene product in prostatic intraepithelial neoplasia and prostate cancer

31 March 2020

1 reference

No mutations found by RET mutation scanning in sporadic and hereditary neuroblastoma

31 March 2020

1 reference

The RET and TRKA pathways collaborate to regulate neuroblastoma differentiation

31 March 2020

1 reference

Neuroblastoma: biological insights into a clinical enigma

31 March 2020

1 reference

RET is a potential tumor suppressor gene in colorectal cancer

31 March 2020

1 reference

The consensus coding sequences of human breast and colorectal cancers

31 March 2020

1 reference

Comprehensive molecular characterization of human colon and rectal cancer

31 March 2020

1 reference

Direct promoter induction of p19Arf by Pit-1 explains the dependence receptor RET/Pit-1/p53-induced apoptosis in the pituitary somatotroph cells

31 March 2020

1 reference

Functional role of the RET dependence receptor, GFRa co-receptors and ligands in the pituitary

31 March 2020

1 reference

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial

31 March 2020

1 reference

Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer

31 March 2020

1 reference

Cabozantinib in progressive medullary thyroid cancer

31 March 2020

1 reference

RET inhibition: implications in cancer therapy.

31 March 2020

1 reference

Lessons learned and questions unanswered from use of multitargeted kinase inhibitors in medullary thyroid cancer

31 March 2020

1 reference

Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma

31 March 2020

1 reference

Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer

31 March 2020

1 reference

Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase

31 March 2020

1 reference

Completing the Arc: targeted inhibition of RET in medullary thyroid cancer

31 March 2020

1 reference

The noninvestigational use of tyrosine kinase inhibitors in thyroid cancer: establishing a standard for patient safety and monitoring.

31 March 2020

1 reference

Site-specific gene expression and localization of growth factor ligand receptors RET, GFRα1 and GFRα2 in human adult colon.

31 March 2020

1 reference

Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system

31 March 2020

1 reference

Pro-survival role for Parkinson's associated gene DJ-1 revealed in trophically impaired dopaminergic neurons

31 March 2020

1 reference

RET is dispensable for maintenance of midbrain dopaminergic neurons in adult mice.

31 March 2020

1 reference

RET signaling is required for survival and normal function of nonpeptidergic nociceptors

31 March 2020

1 reference

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

31 March 2020

1 reference

Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells.

31 March 2020

1 reference

Chemical genetic discovery of targets and anti-targets for cancer polypharmacology

31 March 2020

1 reference

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas

31 March 2020

1 reference

Growth factors and neuropathic pain

31 March 2020

1 reference

GDNF--a potential target to treat addiction

31 March 2020

1 reference

Is GDNF beneficial in Parkinson disease?

31 March 2020

1 reference

Differential expression of c-Ret in motor neurons versus non-neuronal cells is linked to the pathogenesis of ALS.

31 March 2020

1 reference

Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model

31 March 2020

1 reference

NGF utilizes c-Ret via a novel GFL-independent, inter-RTK signaling mechanism to maintain the trophic status of mature sympathetic neurons.

31 March 2020

1 reference

Renal aplasia in humans is associated with RET mutations

31 March 2020

1 reference

Multikinase inhibitors: a new option for the treatment of thyroid cancer.

31 March 2020

1 reference

Developmental expression of the RET protooncogene.

31 March 2020

1 reference

12 December 2020

Co-segregation of MEN2 and Hirschsprung's disease: the same mutation of RET with both gain and loss-of-function?

1 reference

12 December 2020

Human ret proto-oncogene mapped to chromosome 10q11.2.

1 reference

12 December 2020

Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line

1 reference

12 December 2020

Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains

1 reference

12 December 2020

Implication of expression of GDNF/Ret signalling components in differentiation of bone marrow haemopoietic cells

1 reference

12 December 2020

Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival

1 reference

12 December 2020

A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A

1 reference

12 December 2020

Common origin and developmental dependence on c-ret of subsets of enteric and sympathetic neuroblasts.

1 reference

12 December 2020

Ret-mediated mitogenesis requires Src kinase activity.

1 reference

12 December 2020

Polymorphisms G691S/S904S of RET as genetic modifiers of MEN 2A

1 reference

12 December 2020

Characterization of RET proto-oncogene 3' splicing variants and polyadenylation sites: a novel C-terminus for RET

1 reference

12 December 2020

Comprehensive analysis of RET gene should be performed in patients with multiple endocrine neoplasia type 2 (MEN 2) syndrome and no apparent genotype-phenotype correlation: an appraisal of p.Y791F and p.C634Y RET mutations in five unrelated Brazilia

1 reference

12 December 2020

Expression of the c-ret proto-oncogene during mouse embryogenesis

1 reference

12 December 2020

Renal agenesis and hypodysplasia in ret-k- mutant mice result from defects in ureteric bud development

1 reference

12 December 2020

Parent-of-origin effects in multiple endocrine neoplasia type 2B

1 reference

12 December 2020

Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma

1 reference

12 December 2020

Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues.

1 reference

12 December 2020

Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironment.

1 reference

12 December 2020

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC3680

1 reference

Dimensions Publication ID

30 August 2017

1053354163

0 references

1 reference